J.P. Morgan Private Wealth Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $306K | Buy |
6,751
+100
| +2% | +$4.54K | ﹤0.01% | 1467 |
|
|
2023
Q2 | $373K | Sell |
6,651
-781
| -11% | -$43.8K | ﹤0.01% | 1151 |
|
|
2023
Q1 | $336K | Buy |
+7,432
| New | +$336K | ﹤0.01% | 1634 |
|
|
2022
Q4 | – | Sell |
-4,983
| Closed | -$326K | – | 1938 |
|
|
2022
Q3 | $326K | Sell |
4,983
-746
| -13% | -$48.8K | ﹤0.01% | 1621 |
|
|
2022
Q2 | $348K | Sell |
5,729
-1,750
| -23% | -$106K | ﹤0.01% | 1586 |
|
|
2022
Q1 | $469K | Sell |
7,479
-308
| -4% | -$19.3K | ﹤0.01% | 1569 |
|
|
2021
Q4 | $590K | Sell |
7,787
-12,714
| -62% | -$963K | ﹤0.01% | 1485 |
|
|
2021
Q3 | $2.3M | Sell |
20,501
-101,090
| -83% | -$11.3M | 0.01% | 841 |
|
|
2021
Q2 | $19.7M | Buy |
121,591
+116,360
| +2,224% | +$18.8M | 0.05% | 306 |
|
|
2021
Q1 | $637K | Sell |
5,231
-56,985
| -92% | -$6.94M | ﹤0.01% | 1228 |
|
|
2020
Q4 | $9.53M | Buy |
62,216
+51,778
| +496% | +$7.93M | 0.03% | 366 |
|
|
2020
Q3 | $873K | Buy |
10,438
+7,090
| +212% | +$593K | ﹤0.01% | 937 |
|
|
2020
Q2 | $246K | Buy |
+3,348
| New | +$246K | ﹤0.01% | 1387 |
|
|
2020
Q1 | – | Sell |
-4,823
| Closed | -$294K | – | 1437 |
|
|
2019
Q4 | $294K | Buy |
+4,823
| New | +$294K | ﹤0.01% | 1249 |
|